December 4, 2017 / 6:27 AM / in 13 days

BRIEF-Sanofi's Toujeo Met Main Objective In Head-To-Head Study Versus Insulin Degludec

Dec 4 (Reuters) - Sanofi Sa:

* SANOFI‘S TOUJEO® MET MAIN OBJECTIVE IN HEAD-TO-HEAD STUDY VERSUS INSULIN DEGLUDEC Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below